Caxton Associates LLP Takes Position in Agilon Health, Inc. $AGL

Key Points

• Caxton Associates LLP has invested approximately $1.53 million in Agilon Health, Inc., acquiring 353,025 shares to increase its stake in the company to about 0.09% as of the end of the latest quarter.
• Agilon Health's stock price targets have been significantly lowered by various analysts, with Barclays setting a new objective of $1.50 and Jefferies lowering theirs to $1.10.
• Despite a year-over-year revenue decline of 5.9%, Agilon Health reported revenues of $1.39 billion but missed analyst estimates of $1.47 billion and also reported a loss of $0.25 earnings per share.

Caxton Associates LLP bought a new position in shares of Agilon Health, Inc. (NYSE:AGL - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 353,025 shares of the company's stock, valued at approximately $1,529,000. Caxton Associates LLP owned about 0.09% of Agilon Health as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in AGL. Millennium Management LLC increased its holdings in Agilon Health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after purchasing an additional 4,706,357 shares during the last quarter. Nuveen LLC bought a new stake in Agilon Health in the first quarter valued at about $17,242,000. CenterBook Partners LP bought a new stake in Agilon Health in the first quarter valued at about $8,315,000. Invesco Ltd. increased its holdings in Agilon Health by 186.7% in the first quarter. Invesco Ltd. now owns 1,151,795 shares of the company's stock valued at $4,987,000 after purchasing an additional 750,046 shares during the last quarter. Finally, Amundi increased its holdings in Agilon Health by 49.2% in the first quarter. Amundi now owns 1,484,709 shares of the company's stock valued at $5,939,000 after purchasing an additional 489,414 shares during the last quarter.

Agilon Health Stock Performance

NYSE AGL traded up $0.03 during trading hours on Monday, hitting $1.10. 2,221,917 shares of the company traded hands, compared to its average volume of 7,142,719. The business's 50-day moving average is $1.55 and its 200-day moving average is $2.74. Agilon Health, Inc. has a twelve month low of $0.71 and a twelve month high of $6.08. The stock has a market capitalization of $453.79 million, a price-to-earnings ratio of -1.42 and a beta of 0.12.

Agilon Health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The company had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the company posted ($0.07) earnings per share. The business's revenue for the quarter was down 5.9% on a year-over-year basis. Analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on AGL. Sanford C. Bernstein reiterated a "market perform" rating and issued a $1.40 price objective (down previously from $4.00) on shares of Agilon Health in a report on Wednesday, August 20th. Jefferies Financial Group dropped their price objective on Agilon Health from $2.40 to $1.10 and set a "hold" rating for the company in a report on Friday, August 15th. Robert W. Baird dropped their price objective on Agilon Health from $5.00 to $1.00 and set a "neutral" rating for the company in a report on Thursday, August 14th. Evercore ISI dropped their price objective on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a report on Wednesday, July 9th. Finally, Barclays dropped their price objective on Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a report on Wednesday, August 6th. Four research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $3.07.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.